Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-057024
Filing Date
2021-11-15
Accepted
2021-11-15 16:24:28
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-10q_20210930.htm   iXBRL 10-Q 2616471
2 EX-10.1 sprb-ex101_455.htm EX-10.1 24329
3 EX-31.1 sprb-ex311_6.htm EX-31.1 20229
4 EX-31.2 sprb-ex312_7.htm EX-31.2 18887
5 EX-32.1 sprb-ex321_8.htm EX-32.1 8439
6 EX-32.2 sprb-ex322_9.htm EX-32.2 8431
  Complete submission text file 0001564590-21-057024.txt   7603142

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sprb-20210930.xsd EX-101.SCH 50104
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sprb-20210930_cal.xml EX-101.CAL 41398
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sprb-20210930_def.xml EX-101.DEF 143142
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sprb-20210930_lab.xml EX-101.LAB 382304
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sprb-20210930_pre.xml EX-101.PRE 284131
12 EXTRACTED XBRL INSTANCE DOCUMENT sprb-10q_20210930_htm.xml XML 1090837
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 211411099
SIC: 2834 Pharmaceutical Preparations